Financials
- Market Capitalization 214.61 M
- Employee 30
- Founded 2014
- CEO N/A
- Website www.novabridge.com
- Headquarter Cayman Islands
- FIGI BBG00QQ8DFK6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-8.29
Relación precio/flujo de caja
876.63
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3583 | AVXL Anavex Life Sciences Corp. - Common Stock | 2.35 USD | -6.00% | -12.64% | -7.84% | -79.39% | 217.78 M USD | ||
| 3584 | CGEN Compugen Ltd. - Ordinary Shares | 2.30 USD | -3.77% | -1.71% | +13.30% | +42.86% | 217.47 M USD | ||
| 3603 | RNA Atrium Therapeutics, Inc. - Common Stock | 12.22 USD | -1.93% | -7.00% | -1.45% | -82.62% | 209.03 M USD | ||
| 3607 | CLLS Cellectis S.A. - American Depositary Shares | 2.89 USD | -3.34% | -10.80% | -6.77% | +25.65% | 207.36 M USD |